Cue Biopharma
James Murray currently serves as the Associate Director of Toxicology & Pharmacology at Cue Biopharma, a position held since June 2021. Prior to this role, James Murray worked at Genzyme for nearly two decades, where the title held was Staff Scientist I from October 2001 until June 2021.
Cue Biopharma
1 followers
Cue Biopharma is an innovative immunotherapy company dedicated to developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. Cue Biopharma’s Immuno-STAT Biologics are designed to engage directly with and modulate the activity of disease-associated T cells in the patient’s body, potentially offering significant therapeutic advantages while minimizing or eliminating unwanted side effects.